About Us
Verve Therapeutics was created with a singular focus: to protect the world from heart disease
Our Mission
Verve is focused on discovering and developing medicines that safely edit the adult genome and mimic naturally protective gene variants to treat coronary heart disease, the leading cause of death worldwide.
Verve brings together two of the biggest breakthroughs in 21st century biomedicine — human genetic analysis and gene editing — to realize a new future, one of longevity and vitality for tens of millions of people around the globe with or at risk for cardiovascular disease.
Verve Team
Verve has been purpose-built for the task ahead, with a founding team of world-leading experts in cardiovascular medicine, human genetics, gene editing delivery technology and safety, and drug development.


Burt Adelman, M.D.
Co-Founder and Chairman of the Board

Michael Amaonye
Research Associate

Andrew Ashe, J.D.
President and Chief Operating Officer

Aaron Beach
Principal Scientist, Analytical Chemistry

Maggie Beaudoin
Senior Director, Finance

Andrew Bellinger, M.D., Ph.D.
Chief Scientific Officer

Souvik Biswas, Ph.D.
Senior Scientist

Maurine Braun
Senior Manager, Preclinical Operations and Toxicology

Alexandra Chadwick, Ph.D.
Associate Director, Preclinical Research and Development

Huei-Mei Chen, Ph.D.
Senior Scientist, Gene Editing

Christopher J. Cheng, Ph.D.
Director, RNA Technology and Manufacturing

Victoria Clendaniel
Research Associate

Thomas Colace, Ph.D.
Associate Principal Scientist

Angela Cook
Chief of Staff

Ishwin Dembla
Senior Scientist, Analytical Chemistry

Jamie DeNizio, Ph.D.
Scientist

Chaitali Dutta, Ph.D.
Principal Scientist, Pharmacology and Toxicology

Robin Eisner
Administrative and Operations Manager

Jack Ganey
Associate Scientist

Soumya Gangopadhyay, Ph.D.
Senior Scientist, Bioassays and Editing

Sara Garcia, Ph.D.
Senior Scientist, Computational Biology

Ryan Garrity
Senior In Vivo/In Vitro Research Associate

Kevin Gichuru
Accounting Manager

Matthew Greenfield
Associate Director, Laboratory Operations

Sowmya Iyer, Ph.D.
Senior Scientist, Computational Biology

J. Keith Joung, M.D., Ph.D.
Co-Founder

Lisa Kasiewicz, Ph.D.
Scientist

Sekar Kathiresan, M.D.
Co-Founder, Chief Executive Officer and Board Member

Jennifer Lavoie
Associate Director, CMC Program Management

Jimmy Li
Staff Accountant

James Madsen, Ph.D.
Associate Director, Mass Spectrometry

Padma Malyala
Executive Director, Formulation and Characterization

Katie Martinick
Process Development Engineer

Yuri Matsumoto, Ph.D.
Principal Scientist, Bioanalytical and Translational Sciences

Anne Marie Mazzola
Study Coordinator and Scientist, Pharmacology and Toxicology

Taiji Mizoguchi, Ph.D.
Scientist

Kiran Musunuru, M.D., Ph.D., MPH
Co-Founder and Senior Scientific Advisor

Robyn Naigles
Administrative and Operations Associate

Yusuf Nasrullah
Scientist

Joseph Nneji
Senior Research Associate

April O'Neil
Associate Director, Human Resources

Anthony Philippakis, M.D., Ph.D.
Co-Founder and Board Member

Brent V. Powell, Ph.D.
Scientist

Kallanthottathil G. Rajeev, Ph.D.
Vice President, CMC

Caroline Reiss, Ph.D.
Senior Scientist, RNA Technology and Manufacturing

Huilan Ren
Associate Scientist

Ellen Rohde, Ph.D.
Vice President, Pharmacology and Toxicology

Issi Rozen, MBA
Co-Founder and Strategic Advisor

Michele Rozen, MBA
Vice President, Communications

Athul Sanjeev
Research Associate

Wynn Shatzer
Research Associate

Maddy Shay
Research Associate, Formulation and Characterization

Mary Stahley, Ph.D.
Associate Principal Scientist, Process Development and Technology Transfer

Leslie Stolz, Ph.D.
Vice President, Regulatory Affairs

Lynnsey Street
Associate Scientist

Barry Ticho, M.D., Ph.D.
Co-Founder

Scott Vafai, M.D.
Executive Director, Translational Medicine

Kui Wang, Ph.D.
Senior Scientist
Board of Directors

Burt Adelman, M.D.
Co-Founder and Chairman of the Board

Jessica Alston, Ph.D.
Board Observer

Eli Casdin, MBA
Board Observer

John Evans, MBA
Board Member

Sekar Kathiresan, M.D.
Co-Founder, Chief Executive Officer and Board Member

Boris Nikolic, M.D.
Board Observer

Anthony Philippakis, M.D., Ph.D.
Co-Founder and Board Member

Krishna Yeshwant, M.D., MBA
Board Member
Scientific Advisory Board

Eugene Braunwald, M.D.

Andrew Geall, Ph.D.

Penny M. Heaton, M.D.

Daniel J. Rader, M.D.